These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36174838)

  • 21. Antibody Response to mRNA-1273 SARS-CoV-2 Vaccine in Hemodialysis Patients with and without Prior COVID-19.
    Chan L; Fuca N; Zeldis E; Campbell KN; Shaikh A
    Clin J Am Soc Nephrol; 2021 Aug; 16(8):1258-1260. PubMed ID: 34031182
    [No Abstract]   [Full Text] [Related]  

  • 22. Association of malnutrition with SARS-CoV-2 vaccine response in patients undergoing hemodialysis.
    Lin TY; Hung NK; Hung SC
    Clin Nutr; 2022 Dec; 41(12):2683-2690. PubMed ID: 36343559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody Responses after Two Doses of COVID-19 mRNA Vaccine in Dialysis and Kidney Transplantation Patients Recovered from SARS-CoV-2 Infection.
    Cappuccilli M; Semprini S; Fabbri E; Fantini M; Bruno PF; Spazzoli A; Righini M; Flachi M; La Manna G; Sambri V; Mosconi G
    Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888612
    [No Abstract]   [Full Text] [Related]  

  • 24. Humoral Immune Response to COVID-19 Vaccination in Hemodialysis Patients: A Retrospective, Observational Case-Control Pilot Study.
    Piscitani L; Del Pinto R; Basili A; Tunno M; Ferri C
    High Blood Press Cardiovasc Prev; 2022 Mar; 29(2):163-167. PubMed ID: 34978702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune Response to Third and Fourth COVID-19 Vaccination in Hemodialysis Patients and Kidney Transplant Recipients.
    Affeldt P; Koehler FC; Brensing KA; Gies M; Platen E; Adam V; Butt L; Grundmann F; Heger E; Hinrichs S; Kalisch N; Oehm S; Steger G; Wirtz M; Benzing T; Stippel D; Klein F; Kurschat C; Müller RU; Di Cristanziano V
    Viruses; 2022 Nov; 14(12):. PubMed ID: 36560648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of Sinopharm® COVID-19 Vaccine in Hemodialysis Patients: A Preliminary Report.
    Alirezaei A; Fazeli SA; Shafiei M; Miladipour A
    Iran J Kidney Dis; 2022 Jul; 16(4):259-265. PubMed ID: 35962641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and tolerability of COVID-19 vaccination in peritoneal dialysis patients-A prospective observational cohort study.
    Haase M; Lesny P; Haase-Fielitz A; Anderson M; Cloherty G; Stec M; Lucas C; Santos-Araujo C; Haarhaus M; Macario F
    Semin Dial; 2022 May; 35(3):269-277. PubMed ID: 34854131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 mRNA vaccination is not associated with the induction of anti-HLA or non-HLA antibodies.
    Wijtvliet VPWM; Verheyden S; Depreter B; Heylen C; Coeman E; Abrams S; De Winter BY; Massart A; Hellemans R; Pipeleers L; Claas FHJ; Ariën KK; Wissing KM; Abramowicz D; Ledeganck KJ
    Transpl Immunol; 2022 Oct; 74():101670. PubMed ID: 35835296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors predictive of anti-spike antibody titers after COVID-19 vaccination in hemodialysis patients.
    Aoun M; Kahwaji RM; Sleilaty G; Boueri C; Hawi J; Khalil CB; Hage V
    Adv Clin Exp Med; 2022 Aug; 31(8):855-861. PubMed ID: 35438849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody responses to the SARS-CoV-2 vaccines in hemodialysis patients: Is inactivated vaccine effective?
    Murt A; Altiparmak MR; Yadigar S; Yalin SF; Ozbey D; Yildiz Z; Kocazeybek B; Pekpak M; Ataman MR
    Ther Apher Dial; 2022 Aug; 26(4):769-774. PubMed ID: 34741418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired Humoral but Substantial Cellular Immune Response to Variants of Concern B1.1.7 and B.1.351 in Hemodialysis Patients after Vaccination with BNT162b2.
    Thieme CJ; Blazquez-Navarro A; Safi L; Kaliszczyk S; Paniskaki K; Neumann IE; Schmidt K; Stockhausen M; Hörstrup J; Cinkilic O; Flitsch-Kiefner L; Meister TL; Marheinecke C; Pfaender S; Steinmann E; Seibert FS; Stervbo U; Westhoff TH; Roch T; Babel N
    J Am Soc Nephrol; 2021 Nov; 32(11):2725-2727. PubMed ID: 34716240
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of long-term antibody response to mRNA SARS-CoV-2 vaccine among peritoneal dialysis and hemodialysis patients.
    Nacasch N; Cohen-Hagai K; Benchetrit S; Zitman-Gal T; Einbinder Y; Erez D; Hornik-Lurie T; Goldman S; Tanasiychuk T; Frajewicki V; Magen S; Wiener-Well Y; Bnaya A; Shavit L
    Nephrol Dial Transplant; 2022 Feb; 37(3):602-604. PubMed ID: 34788861
    [No Abstract]   [Full Text] [Related]  

  • 33. Humoral Response and SARS-CoV-2 Infection Risk following the Third and Fourth Doses of the BNT162b2 Vaccine in Dialysis Patients.
    Einbinder Y; Perl J; Nacasch N; Bnaya A; Shavit L; Erez D; Shashar M; Halperin T; Grupper A; Benchetrit S; Wand O; Cohen-Hagai K
    Am J Nephrol; 2022; 53(7):586-590. PubMed ID: 35850101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of SARS-CoV-2 vaccines on hemodialysis patients in Japan: A nationwide cohort study.
    Kikuchi K; Nangaku M; Ryuzaki M; Yamakawa T; Yoshihiro O; Hanafusa N; Sakai K; Kanno Y; Ando R; Shinoda T; Wakino S; Nakamoto H; Takemoto Y; Akizawa T;
    Ther Apher Dial; 2023 Feb; 27(1):19-23. PubMed ID: 35610734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity and safety of SARS-CoV-2 vaccine in hemodialysis patients: A systematic review and meta-analysis.
    Peiyao R; Mengjie Y; Xiaogang S; Wenfang H; Danna Z; Yuqun Z; Juan J; Qiang H
    Front Public Health; 2022; 10():951096. PubMed ID: 36211647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses.
    Anft M; Blazquez-Navarro A; Frahnert M; Fricke L; Meister TL; Roch T; Stervbo U; Pfaender S; Westhoff TH; Babel N
    Kidney Int; 2022 Jul; 102(1):207-208. PubMed ID: 35580654
    [No Abstract]   [Full Text] [Related]  

  • 37. Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination.
    Dulovic A; Strengert M; Ramos GM; Becker M; Griesbaum J; Junker D; Lürken K; Beigel A; Wrenger E; Lonnemann G; Cossmann A; Stankov MV; Dopfer-Jablonka A; Kaiser PD; Traenkle B; Rothbauer U; Krause G; Schneiderhan-Marra N; Behrens GMN
    Emerg Infect Dis; 2022 Apr; 28(4):743-750. PubMed ID: 35203113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 spike protein antibody titers 6 months after SARS-CoV-2 mRNA vaccination among patients undergoing hemodialysis in Japan.
    Kanai D; Wakui H; Haze T; Azushima K; Kinguchi S; Tsukamoto S; Kanaoka T; Urate S; Toya Y; Hirawa N; Kato H; Watanabe F; Hanaoka K; Hanaoka M; Mitsuhashi H; Yamaguchi S; Ohnishi T; Tamura K
    Clin Exp Nephrol; 2022 Oct; 26(10):988-996. PubMed ID: 35751753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients - the Vienna Cohort.
    Beilhack G; Monteforte R; Frommlet F; Gaggl M; Strassl R; Vychytil A
    Front Immunol; 2021; 12():780594. PubMed ID: 34925359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Humoral Response to mRNA versus an Adenovirus Vector-Based SARS-CoV-2 Vaccine in Dialysis Patients.
    Mulhern JG; Fadia A; Patel R; Ficociello LH; Willetts J; Dahne-Steuber IA; Pollan MC; Mullon C; DeLisi J; Johnson C; Mysayphonh C; Kossmann RJ; Anger MS; Hymes JL
    Clin J Am Soc Nephrol; 2021 Nov; 16(11):1720-1722. PubMed ID: 34312162
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.